France's first medical cannabis diploma
Who says experimentation with therapeutic cannabis, and its possible subsequent generalization, means training for medical staff.
From January 2021, the Universities of Montpellier and Paris-Saclay will be offering the first inter-university diploma «Du bon usage du cannabis thérapeutique» ("On the proper use of therapeutic cannabis").
Delivered by videoconference, Covid obliges, the training «will aim to provide theoretical and practical university training on the administration of products containing cannabis as part of the generalization of the French experiment planned for the end of 2021. It will enable the acquisition of cross-disciplinary skills in prescribing and supporting patients suffering from pathologies requiring the use of medical cannabis.»
The course includes 50 hours of lectures by Professor Pierre Labauge from Montpellier University Hospital and Professor Amine Benyamina from Université Paris Sud. Among the skills to be acquired, the training aims to ensure that :
- Identify patients who are eligible for medical cannabis prescriptions
- Prescribing skills (for doctors) and dispensing skills (for pharmacists)
- Communicate the different effects of medical cannabis and its various uses
- Controlling the dosage of cannabis-containing products
A dissertation and a final written exam will complete the course.
Places are limited and pre-registration is open here and here.
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


You must be logged in to post a comment Login